Giuseppe Di Giovanni

Author

Also Known As

Bentham Science Publisher Bentham Science Publisher, DI GIOVANNI, Giuseppe, DI MAIO, Roberto, Di Giovanni, Giuseppe, E Del Vecchio, E. Del Vecchio, G DIGIOVANNI, G Di Giovanni, G di Giovanni, G. DI GIOVANNI

319

Publications

11K

Citations

H-Index

109

Concepts

All Affiliations

University of Malta Cardiff University University of Palermo Mario Negri Sud Foundation Centre National de la Recherche Scientifique

About

Giuseppe Di Giovanni is an author at University of Malta specializing in medicine, neuroscience, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	47	3.1K
2	Health Sciences	8	8	185
3	Public Health	2	2	417
4	Education	1	1	14
5	Engineering	1	1	12

Giuseppe Di Giovanni

Publications

5.2K

Citations

H-Index

Page 1

	Year	Citations
Enhanced tonic GABAA inhibition in typical absence epilepsy David W. Cope, Giuseppe Di Giovanni, Sarah J. Fyson, Nature Medicine NeurophysiologyTypical Absence EpilepsyNeurologyNeuroscienceCentral Nervous System	2009	417
Effect of Evolocumab on Coronary Plaque Phenotype and Burden in Statin-Treated Patients Following Myocardial Infarction Stephen J. Nicholls, Yu Kataoka, Steven E. Nissen, JACC. Cardiovascular imaging Coronary Plaque PhenotypeCardiovascular DiseaseAtherosclerosisPharmacologyPharmacotherapy	2022	392
SB 242 084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system Vincenzo Di Matteo, Giuseppe Di Giovanni, Michele Di Mascio, Neuropharmacology MedicineNeurotransmitterPsychopharmacologyNeuropharmacologyNeuroscience	1999	246
Essential Thalamic Contribution to Slow Waves of Natural Sleep François David, Joscha T. Schmiedt, Hannah L. Taylor, Journal of Neuroscience	2013	234
Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study Giuseppe Di Giovanni, Philippe De Deurwaerdère, Michele Di Mascio, Neuroscience Mesostriatal Dopaminergic FunctionSelective BlockadeNeurophysiologyMedicineMicrodialysis Study	1999	219
Biochemical and electrophysiological evidence that RO 60-0175 inhibits mesolimbic dopaminergic function through serotonin2C receptors Vincenzo Di Matteo, Giuseppe Di Giovanni, Michele Di Mascio, Brain Research MedicineRo 60-0175 InhibitsPhysiologySerotonin2c ReceptorsPsychotropic Medication	2000	182
Effect of Serial Infusions of CER-001, a Pre-β High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome Trial Stephen J. Nicholls, Jordan Andrews, John J.P. Kastelein, JAMA Cardiology	2018	178
Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin2C/2B receptor agonists: a combined in vivo electrophysiological and microdialysis study Giuseppe Di Giovanni, Vincenzo Di Matteo, Michele Di Mascio, Synapse	2000	177
Cortical drive and thalamic feed-forward inhibition control thalamic output synchrony during absence seizures Cian McCafferty, François David, Marcello Venzi, Nature Neuroscience NeurodynamicsNeurophysiologyCortical DriveNeuromodulation TherapiesNeurological Function	2018	131
m-Chlorophenylpiperazine excites non-dopaminergic neurons in the rat substantia nigra and ventral tegmental area by activating serotonin-2C receptors Giuseppe Di Giovanni, Vincenzo Di Matteo, V La Grutta, Neuroscience NeurophysiologyNeuroanatomyBehavioral NeurosciencePhysiologyMonoamine Neurotransmitters	2001	124

Page 1